Faricimab Injection [Vabysmo] Clinical Trials
3 recruitingDrug
Phase 42Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 3
Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy
Polypoidal Choroidal Vasculopathy (PCV)
Yeungnam University College of Medicine50 enrolled1 locationNCT07461441
Recruiting
Phase 4
Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)
Polypoidal Choroidal Vasculopathy
Association for Innovation and Biomedical Research on Light and Image120 enrolled31 locationsNCT06709339
Recruiting
Phase 4
Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration
Macular Degeneration Choroidal Neovascularization
Hospital Authority, Hong Kong40 enrolled1 locationNCT06742307